Form 4 holding
Co-CEO, Director
Amneal Pharmaceuticals, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 24,753,252
- Estimated value
- $428,478,792
- Report date
- 10 Aug 2026
- Price
- $17.31
- Ownership
- By Family Trusts